SPRO Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Spero Therapeutics Inc - Alpha Spread

Spero Therapeutics Inc
NASDAQ:SPRO

Watchlist Manager
Spero Therapeutics Inc Logo
Spero Therapeutics Inc
NASDAQ:SPRO
Watchlist
Price: 1.25 USD 0.81% Market Closed
Market Cap: 67.6m USD
Have any thoughts about
Spero Therapeutics Inc?
Write Note

Wall Street
Price Targets

SPRO Price Targets Summary
Spero Therapeutics Inc

Wall Street analysts forecast SPRO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRO is 7.65 USD with a low forecast of 7.07 USD and a high forecast of 8.4 USD.

Lowest
Price Target
7.07 USD
466% Upside
Average
Price Target
7.65 USD
512% Upside
Highest
Price Target
8.4 USD
572% Upside
Spero Therapeutics Inc Competitors:
Price Targets
KYMR
Kymera Therapeutics Inc
26% Upside
688105
Nanjing Vazyme Biotech Co Ltd
1% Upside
096530
Seegene Inc
62% Upside
SLRN
ACELYRIN Inc
99% Upside
BIOPOR
Bioporto A/S
66% Upside
4974
Takara Bio Inc
52% Upside
2696
Shanghai Henlius Biotech Inc
1% Upside
VCYT
Veracyte Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Spero Therapeutics Inc

For the last 7 years the compound annual growth rate for Spero Therapeutics Inc's revenue is 126%. The projected CAGR for the next 3 years is -43%.

126%
Past Growth
-43%
Estimated Growth
Estimates Accuracy
29%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Spero Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Spero Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPRO's stock price target?
Price Target
7.65 USD

According to Wall Street analysts, the average 1-year price target for SPRO is 7.65 USD with a low forecast of 7.07 USD and a high forecast of 8.4 USD.

What is Spero Therapeutics Inc's Revenue forecast?
Projected CAGR
-43%

For the last 7 years the compound annual growth rate for Spero Therapeutics Inc's revenue is 126%. The projected CAGR for the next 3 years is -43%.

Back to Top